Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
57
BKIV Quote, Financials, Valuation and Earnings
Last price:
$36.09
Seasonality move
:
10.73%
Day range:
$35.99 - $35.99
52-week range:
$27.83 - $38.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
1.7K
Avg. volume:
--
1-year change:
28.99%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BKIV
BNY Mellon Innovators ETF
|
-- | -- | -- | -- | -- |
|
ASG
Liberty All Star Growth Fund
|
-- | -- | -- | -- | -- |
|
FFTY
Innovator IBD 50 ETF
|
-- | -- | -- | -- | -- |
|
FRTY
Alger Mid Cap 40 ETF
|
-- | -- | -- | -- | -- |
|
JMID
Janus Henderson Mid Cap Growth Alpha ETF
|
-- | -- | -- | -- | -- |
|
MID
American Century Mid Cap Growth Impact ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BKIV
BNY Mellon Innovators ETF
|
$36.09 | -- | -- | -- | $0.00 | 0% | -- |
|
ASG
Liberty All Star Growth Fund
|
$5.70 | -- | -- | -- | $0.12 | 4.2% | -- |
|
FFTY
Innovator IBD 50 ETF
|
$29.84 | -- | -- | -- | $0.16 | 0.53% | -- |
|
FRTY
Alger Mid Cap 40 ETF
|
$19.26 | -- | -- | -- | $0.02 | 0.1% | -- |
|
JMID
Janus Henderson Mid Cap Growth Alpha ETF
|
$28.45 | -- | -- | -- | $0.03 | 0.1% | -- |
|
MID
American Century Mid Cap Growth Impact ETF
|
$61.32 | -- | -- | -- | $0.04 | 0.17% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BKIV
BNY Mellon Innovators ETF
|
-- | 1.489 | -- | -- |
|
ASG
Liberty All Star Growth Fund
|
-- | 0.977 | -- | -- |
|
FFTY
Innovator IBD 50 ETF
|
-- | 1.958 | -- | -- |
|
FRTY
Alger Mid Cap 40 ETF
|
-- | 1.318 | -- | -- |
|
JMID
Janus Henderson Mid Cap Growth Alpha ETF
|
-- | 0.000 | -- | -- |
|
MID
American Century Mid Cap Growth Impact ETF
|
-- | 1.267 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BKIV
BNY Mellon Innovators ETF
|
-- | -- | -- | -- | -- | -- |
|
ASG
Liberty All Star Growth Fund
|
-- | -- | -- | -- | -- | -- |
|
FFTY
Innovator IBD 50 ETF
|
-- | -- | -- | -- | -- | -- |
|
FRTY
Alger Mid Cap 40 ETF
|
-- | -- | -- | -- | -- | -- |
|
JMID
Janus Henderson Mid Cap Growth Alpha ETF
|
-- | -- | -- | -- | -- | -- |
|
MID
American Century Mid Cap Growth Impact ETF
|
-- | -- | -- | -- | -- | -- |
BNY Mellon Innovators ETF vs. Competitors
-
Which has Higher Returns BKIV or ASG?
Liberty All Star Growth Fund has a net margin of -- compared to BNY Mellon Innovators ETF's net margin of --. BNY Mellon Innovators ETF's return on equity of -- beat Liberty All Star Growth Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BKIVBNY Mellon Innovators ETF-- -- -- ASGLiberty All Star Growth Fund-- -- -- -
What do Analysts Say About BKIV or ASG?
BNY Mellon Innovators ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Liberty All Star Growth Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that BNY Mellon Innovators ETF has higher upside potential than Liberty All Star Growth Fund, analysts believe BNY Mellon Innovators ETF is more attractive than Liberty All Star Growth Fund.
Company Buy Ratings Hold Ratings Sell Ratings BKIVBNY Mellon Innovators ETF0 0 0 ASGLiberty All Star Growth Fund0 0 0 -
Is BKIV or ASG More Risky?
BNY Mellon Innovators ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Liberty All Star Growth Fund has a beta of 1.342, suggesting its more volatile than the S&P 500 by 34.161%.
-
Which is a Better Dividend Stock BKIV or ASG?
BNY Mellon Innovators ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Liberty All Star Growth Fund offers a yield of 4.2% to investors and pays a quarterly dividend of $0.12 per share. BNY Mellon Innovators ETF pays -- of its earnings as a dividend. Liberty All Star Growth Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BKIV or ASG?
BNY Mellon Innovators ETF quarterly revenues are --, which are smaller than Liberty All Star Growth Fund quarterly revenues of --. BNY Mellon Innovators ETF's net income of -- is lower than Liberty All Star Growth Fund's net income of --. Notably, BNY Mellon Innovators ETF's price-to-earnings ratio is -- while Liberty All Star Growth Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BNY Mellon Innovators ETF is -- versus -- for Liberty All Star Growth Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BKIVBNY Mellon Innovators ETF-- -- -- -- ASGLiberty All Star Growth Fund-- -- -- --
-
Which has Higher Returns BKIV or FFTY?
Innovator IBD 50 ETF has a net margin of -- compared to BNY Mellon Innovators ETF's net margin of --. BNY Mellon Innovators ETF's return on equity of -- beat Innovator IBD 50 ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BKIVBNY Mellon Innovators ETF-- -- -- FFTYInnovator IBD 50 ETF-- -- -- -
What do Analysts Say About BKIV or FFTY?
BNY Mellon Innovators ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Innovator IBD 50 ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that BNY Mellon Innovators ETF has higher upside potential than Innovator IBD 50 ETF, analysts believe BNY Mellon Innovators ETF is more attractive than Innovator IBD 50 ETF.
Company Buy Ratings Hold Ratings Sell Ratings BKIVBNY Mellon Innovators ETF0 0 0 FFTYInnovator IBD 50 ETF0 0 0 -
Is BKIV or FFTY More Risky?
BNY Mellon Innovators ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Innovator IBD 50 ETF has a beta of 1.186, suggesting its more volatile than the S&P 500 by 18.613%.
-
Which is a Better Dividend Stock BKIV or FFTY?
BNY Mellon Innovators ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Innovator IBD 50 ETF offers a yield of 0.53% to investors and pays a quarterly dividend of $0.16 per share. BNY Mellon Innovators ETF pays -- of its earnings as a dividend. Innovator IBD 50 ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BKIV or FFTY?
BNY Mellon Innovators ETF quarterly revenues are --, which are smaller than Innovator IBD 50 ETF quarterly revenues of --. BNY Mellon Innovators ETF's net income of -- is lower than Innovator IBD 50 ETF's net income of --. Notably, BNY Mellon Innovators ETF's price-to-earnings ratio is -- while Innovator IBD 50 ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BNY Mellon Innovators ETF is -- versus -- for Innovator IBD 50 ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BKIVBNY Mellon Innovators ETF-- -- -- -- FFTYInnovator IBD 50 ETF-- -- -- --
-
Which has Higher Returns BKIV or FRTY?
Alger Mid Cap 40 ETF has a net margin of -- compared to BNY Mellon Innovators ETF's net margin of --. BNY Mellon Innovators ETF's return on equity of -- beat Alger Mid Cap 40 ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BKIVBNY Mellon Innovators ETF-- -- -- FRTYAlger Mid Cap 40 ETF-- -- -- -
What do Analysts Say About BKIV or FRTY?
BNY Mellon Innovators ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Alger Mid Cap 40 ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that BNY Mellon Innovators ETF has higher upside potential than Alger Mid Cap 40 ETF, analysts believe BNY Mellon Innovators ETF is more attractive than Alger Mid Cap 40 ETF.
Company Buy Ratings Hold Ratings Sell Ratings BKIVBNY Mellon Innovators ETF0 0 0 FRTYAlger Mid Cap 40 ETF0 0 0 -
Is BKIV or FRTY More Risky?
BNY Mellon Innovators ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Alger Mid Cap 40 ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BKIV or FRTY?
BNY Mellon Innovators ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alger Mid Cap 40 ETF offers a yield of 0.1% to investors and pays a quarterly dividend of $0.02 per share. BNY Mellon Innovators ETF pays -- of its earnings as a dividend. Alger Mid Cap 40 ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BKIV or FRTY?
BNY Mellon Innovators ETF quarterly revenues are --, which are smaller than Alger Mid Cap 40 ETF quarterly revenues of --. BNY Mellon Innovators ETF's net income of -- is lower than Alger Mid Cap 40 ETF's net income of --. Notably, BNY Mellon Innovators ETF's price-to-earnings ratio is -- while Alger Mid Cap 40 ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BNY Mellon Innovators ETF is -- versus -- for Alger Mid Cap 40 ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BKIVBNY Mellon Innovators ETF-- -- -- -- FRTYAlger Mid Cap 40 ETF-- -- -- --
-
Which has Higher Returns BKIV or JMID?
Janus Henderson Mid Cap Growth Alpha ETF has a net margin of -- compared to BNY Mellon Innovators ETF's net margin of --. BNY Mellon Innovators ETF's return on equity of -- beat Janus Henderson Mid Cap Growth Alpha ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BKIVBNY Mellon Innovators ETF-- -- -- JMIDJanus Henderson Mid Cap Growth Alpha ETF-- -- -- -
What do Analysts Say About BKIV or JMID?
BNY Mellon Innovators ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Janus Henderson Mid Cap Growth Alpha ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that BNY Mellon Innovators ETF has higher upside potential than Janus Henderson Mid Cap Growth Alpha ETF, analysts believe BNY Mellon Innovators ETF is more attractive than Janus Henderson Mid Cap Growth Alpha ETF.
Company Buy Ratings Hold Ratings Sell Ratings BKIVBNY Mellon Innovators ETF0 0 0 JMIDJanus Henderson Mid Cap Growth Alpha ETF0 0 0 -
Is BKIV or JMID More Risky?
BNY Mellon Innovators ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Janus Henderson Mid Cap Growth Alpha ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BKIV or JMID?
BNY Mellon Innovators ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Janus Henderson Mid Cap Growth Alpha ETF offers a yield of 0.1% to investors and pays a quarterly dividend of $0.03 per share. BNY Mellon Innovators ETF pays -- of its earnings as a dividend. Janus Henderson Mid Cap Growth Alpha ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BKIV or JMID?
BNY Mellon Innovators ETF quarterly revenues are --, which are smaller than Janus Henderson Mid Cap Growth Alpha ETF quarterly revenues of --. BNY Mellon Innovators ETF's net income of -- is lower than Janus Henderson Mid Cap Growth Alpha ETF's net income of --. Notably, BNY Mellon Innovators ETF's price-to-earnings ratio is -- while Janus Henderson Mid Cap Growth Alpha ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BNY Mellon Innovators ETF is -- versus -- for Janus Henderson Mid Cap Growth Alpha ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BKIVBNY Mellon Innovators ETF-- -- -- -- JMIDJanus Henderson Mid Cap Growth Alpha ETF-- -- -- --
-
Which has Higher Returns BKIV or MID?
American Century Mid Cap Growth Impact ETF has a net margin of -- compared to BNY Mellon Innovators ETF's net margin of --. BNY Mellon Innovators ETF's return on equity of -- beat American Century Mid Cap Growth Impact ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BKIVBNY Mellon Innovators ETF-- -- -- MIDAmerican Century Mid Cap Growth Impact ETF-- -- -- -
What do Analysts Say About BKIV or MID?
BNY Mellon Innovators ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand American Century Mid Cap Growth Impact ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that BNY Mellon Innovators ETF has higher upside potential than American Century Mid Cap Growth Impact ETF, analysts believe BNY Mellon Innovators ETF is more attractive than American Century Mid Cap Growth Impact ETF.
Company Buy Ratings Hold Ratings Sell Ratings BKIVBNY Mellon Innovators ETF0 0 0 MIDAmerican Century Mid Cap Growth Impact ETF0 0 0 -
Is BKIV or MID More Risky?
BNY Mellon Innovators ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison American Century Mid Cap Growth Impact ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BKIV or MID?
BNY Mellon Innovators ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. American Century Mid Cap Growth Impact ETF offers a yield of 0.17% to investors and pays a quarterly dividend of $0.04 per share. BNY Mellon Innovators ETF pays -- of its earnings as a dividend. American Century Mid Cap Growth Impact ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BKIV or MID?
BNY Mellon Innovators ETF quarterly revenues are --, which are smaller than American Century Mid Cap Growth Impact ETF quarterly revenues of --. BNY Mellon Innovators ETF's net income of -- is lower than American Century Mid Cap Growth Impact ETF's net income of --. Notably, BNY Mellon Innovators ETF's price-to-earnings ratio is -- while American Century Mid Cap Growth Impact ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BNY Mellon Innovators ETF is -- versus -- for American Century Mid Cap Growth Impact ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BKIVBNY Mellon Innovators ETF-- -- -- -- MIDAmerican Century Mid Cap Growth Impact ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 2.79% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 6.8% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 5.31% over the past day.
